TAMEC: a new analogue of cyclomyrsinol diterpenes decreases anxiety- and depression-like behaviors in a mouse model of multiple sclerosis

References

• Majidi-Zolbanin J, Doosti M-H, Kosari-Nasab M, Salari A-A. Prenatal maternal immune activation increases anxiety-and depressive-like behaviors in offspring with experimental autoimmune encephalomyelitis. Neurosci. 2015;294:69–81.10.1016/j.neuroscience.2015.03.016
   PubMed Web of Science ®Google Scholar
• Feinstein A. The neuropsychiatry of multiple sclerosis. Can J Psychiatry. 2004;49:157–163.10.1177/070674370404900302
   PubMed Web of Science ®Google Scholar
• Marrie RA, Reingold S, Cohen J, et al. The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review, Mult Scler J. 2015;21:305–317.
   PubMed Web of Science ®Google Scholar
• Fiest K, Walker J, Bernstein C, et al. Systematic review and meta-analysis of interventions for depression and anxiety in persons with multiple sclerosis. Mult Scler Relat Disord 2016;5:12–26.
   PubMed Web of Science ®Google Scholar
• Eyre HA, Air T, Pradhan A, et al. A meta-analysis of chemokines in major depression. Prog Neuro-Psychopharmacol Biol Psychiatry. 2016;68:1–8.10.1016/j.pnpbp.2016.02.006
   PubMed Web of Science ®Google Scholar
• Salim S, Chugh G, Asghar M. Inflammation in anxiety. Adv Protein Chem Struct Biol 2012;88:1–25.
   PubMed Web of Science ®Google Scholar
• Majidi J, Kosari-Nasab M, Salari A-A. Developmental minocycline treatment reverses the effects of neonatal immune activation on anxiety-and depression-like behaviors, hippocampal inflammation, and HPA axis activity in adult mice. Brain Res Bull. 2016;120:1–13.10.1016/j.brainresbull.2015.10.009
   PubMed Web of Science ®Google Scholar
• Ransohoff RM. Animal models of multiple sclerosis: the good, the bad and the bottom line. Nature Neurosci. 2012;15:1074–1077.10.1038/nn.3168
   PubMed Web of Science ®Google Scholar
• Colasanti A, Guo Q, Giannetti P, et al. Hippocampal neuroinflammation, functional connectivity, and depressive symptoms in multiple sclerosis. Biol Psychiatry. 2016;80:62–72.10.1016/j.biopsych.2015.11.022
   PubMed Web of Science ®Google Scholar
• Nestler EJ, Barrot M, DiLeone RJ, et al. Neurobiol of depression. Neuron. 2002;34:13–25.10.1016/S0896-6273(02)00653-0
   PubMed Web of Science ®Google Scholar
• Bannerman D, Rawlins J, McHugh S. Regional dissociations within the hippocampus—memory and anxiety. Neurosci Biobehav Rev. 2004;28:273–283.
   PubMed Web of Science ®Google Scholar
• Newman DJ, Cragg GM. Natural products as sources of new drugs from 1981 to 2014. J Nat Prod. 2016;79:629–661.10.1021/acs.jnatprod.5b01055
   PubMed Web of Science ®Google Scholar
• Mishra BB, Tiwari VK. Natural products: an evolving role in future drug discovery. Eur J Med Chem. 2011;46:4769–4807.10.1016/j.ejmech.2011.07.057
   PubMed Web of Science ®Google Scholar
• Zécri FJ. From natural product to the first oral treatment for multiple sclerosis: the discovery of FTY720 (Gilenya™)? Curr Opin Chem Biol. 2016;32:60–66.10.1016/j.cbpa.2016.04.014
   PubMed Web of Science ®Google Scholar
• Sarris J, Panossian A, Schweitzer I, et al. Herbal medicine for depression, anxiety and insomnia: a review of psychopharmacology and clinical evidence. Eur Neuropsychopharmacol. 2011;21:841–860.10.1016/j.euroneuro.2011.04.002
   PubMed Web of Science ®Google Scholar
• Vasas A, Rédei D, Csupor D, et al. Diterpenes from European euphorbia species serving as prototypes for natural-product-based drug discovery. Eur J Org Chem. 2012;2012:5115–5130.10.1002/ejoc.201200733
   Web of Science ®Google Scholar
• Ghanadian SM, Ayatollahi AM, Afsharypuor S, et al. New mirsinane-type diterpenes from Euphorbia microsciadia Boiss. with inhibitory effect on VEGF-induced angiogenesis. J Nat Med. 2013;67:327–32.
   PubMed Web of Science ®Google Scholar
• Zolfaghari B, Yazdiniapour Z, Ghanadian M, et al. Cyclomyrsinane and premyrsinane diterpenes from Euphorbia sogdiana Popov. Tetrahedron. 2016;72:5394–5401.10.1016/j.tet.2016.07.027
   Web of Science ®Google Scholar
• Ghanadian M, Choudhary MI, Ayatollahi AM, et al. New cyclomyrsinol diterpenes from Euphorbia aellenii with their immunomodulatory effects. J Asian Nat Prod Res. 2013;15:22–29.10.1080/10286020.2012.742073
   PubMed Web of Science ®Google Scholar
• Ghanadian SM, Ayatollahi AM, Mesaik MA, et al. New immunosuppressive cyclomyrsinol diterpenes from Euphorbia kopetdaghi Prokh. Nat Prod Res. 2013;27:246–254.10.1080/14786419.2012.671318
   PubMed Web of Science ®Google Scholar
• Salari A-A, Amani M. Neonatal blockade of GABA-A receptors alters behavioral and physiological phenotypes in adult mice. Int J Dev Neurosci. 2017;57:62–71.10.1016/j.ijdevneu.2017.01.007
   PubMed Web of Science ®Google Scholar
• Salari A-A, Fatehi-Gharehlar L, Motayagheni N, et al. Fluoxetine normalizes the effects of prenatal maternal stress on depression-and anxiety-like behaviors in mouse dams and male offspring. Behav Brain Res. 2016;311:354–367.10.1016/j.bbr.2016.05.062
   PubMed Web of Science ®Google Scholar
• Salari A-A, Bakhtiari A, Homberg JR. Activation of GABA-A receptors during postnatal brain development increases anxiety-and depression-related behaviors in a time-and dose-dependent manner in adult mice. Eur Neuropsychopharmacol. 2015;25:1260–1274.10.1016/j.euroneuro.2015.04.022
   PubMed Web of Science ®Google Scholar
• Babri S, Doosti M-H, Salari A-A. Strain-dependent effects of prenatal maternal immune activation on anxiety-and depression-like behaviors in offspring. Brain Behav Immun. 2014;37:164–176.10.1016/j.bbi.2013.12.003
   PubMed Web of Science ®Google Scholar
• Amani M, Samadi H, Doosti M-H, et al. Neonatal NMDA receptor blockade alters anxiety-and depression-related behaviors in a sex-dependent manner in mice. Neuropharmacol. 2013;73:87–97.10.1016/j.neuropharm.2013.04.056
   PubMed Web of Science ®Google Scholar
• Solati J, Asiaei M, Haji Molla Hoseini M. Using experimental autoimmune encephalomyelitis as a model to study the effect of prenatal stress on fetal programming. Neurol Res. 2012;34:478–483.
   PubMed Web of Science ®Google Scholar
• Marck CH, Neate SL, Taylor KL, et al. Prevalence of comorbidities, overweight and obesity in an international sample of people with multiple sclerosis and associations with modifiable lifestyle factors. PLoS One. 2016;11:e0148573.
   PubMed Web of Science ®Google Scholar
• Peruga I, Hartwig S, Thöne J, et al. Inflammation modulates anxiety in an animal model of multiple sclerosis. Behav Brain Res. 2011;220:20–29.10.1016/j.bbr.2011.01.018
   PubMed Web of Science ®Google Scholar
• Sapolsky RM. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry. 2000;57:925–935.10.1001/archpsyc.57.10.925
   PubMed Web of Science ®Google Scholar
• Loftis JM, Huckans M, Morasco BJ. Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies. Neurobiol Dis. 2010;37:519–533.10.1016/j.nbd.2009.11.015
   PubMed Web of Science ®Google Scholar
• Koo JW, Duman RS. Evidence for IL-1 receptor blockade as a therapeutic strategy for the treatment of depression. Curr Opin Investig Drugs (London, England: 2000) 2009;10:664.
   PubMedGoogle Scholar
• Babri S, Doosti M-H, Salari A-A. Tumor necrosis factor-alpha during neonatal brain development affects anxiety-and depression-related behaviors in adult male and female mice. Behav Brain Res. 2014;261:305–314.10.1016/j.bbr.2013.12.037
   PubMed Web of Science ®Google Scholar
• Del Grande da Silva G, Wiener CD, Barbosa LP, et al. Pro-inflammatory cytokines and psychotherapy in depression: results from a randomized clinical trial. J Psychiatr Res. 2016;75:57–64.10.1016/j.jpsychires.2016.01.008
   PubMed Web of Science ®Google Scholar
• Kaster MP, Gadotti VM, Calixto JB, et al. Depressive-like behavior induced by tumor necrosis factor-α in mice. Neuropharmacol. 2012;62:419–426.10.1016/j.neuropharm.2011.08.018
   PubMed Web of Science ®Google Scholar
• Rossi S, Sacchetti L, Napolitano F, et al. Interleukin-1β causes anxiety by interacting with the endocannabinoid system. J Neurosci. 2012;32:13896–13905.10.1523/JNEUROSCI.1515-12.2012
   PubMed Web of Science ®Google Scholar
• Hein AM, Zarcone TJ, Parfitt DB, et al. Behavioral, structural and molecular changes following long-term hippocampal IL-1β overexpression in transgenic mice. J Neuroimmune Pharmacol. 2012;7:145–155.10.1007/s11481-011-9294-3
   PubMed Web of Science ®Google Scholar
• Bayramgürler D, Karson A, Özer C, et al. Effects of long-term etanercept treatment on anxiety-and depression-like neurobehaviors in rats. Physiol Behav. 2013;119:145–148.10.1016/j.physbeh.2013.06.010
   PubMed Web of Science ®Google Scholar
• Simen BB, Duman CH, Simen AA, et al. TNFα signaling in depression and anxiety: behavioral consequences of individual receptor targeting. Biol Psychiatry. 2006;59:775–785.10.1016/j.biopsych.2005.10.013
   PubMed Web of Science ®Google Scholar
• Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67:446–457.10.1016/j.biopsych.2009.09.033
   PubMed Web of Science ®Google Scholar
• Bonfiglio T, Olivero G, Merega E, et al. M Prophylactic versus Therapeutic Fingolimod: Restoration of Presynaptic Defects in Mice Suffering from Experimental Autoimmune Encephalomyelitis. PLoS One. 2017;12:e0170825.10.1371/journal.pone.0170825
   PubMed Web of Science ®Google Scholar
• Vollmar P, Nessler S, Kalluri SR, et al. The antidepressant venlafaxine ameliorates murine experimental autoimmune encephalomyelitis by suppression of pro-inflammatory cytokines. Int J Neuropsychopharmacol. 2009;12:525–536.10.1017/S1461145708009425
   PubMed Web of Science ®Google Scholar
• Yuan XQ, Qiu G, Liu XJ, et al. Fluoxetine promotes remission in acute experimental autoimmune encephalomyelitis in rats. Neuroimmunomodulation. 2012;19:201–208.10.1159/000334095
   PubMed Web of Science ®Google Scholar
• Jones KA, Thomsen C. The role of the innate immune system in psychiatric disorders. Mol Cell Neurosci. 2013;53:52–62.10.1016/j.mcn.2012.10.002
   PubMed Web of Science ®Google Scholar
• Söderlund J, Olsson SK, Samuelsson M, et al. Elevation of cerebrospinal fluid interleukin-1β in bipolar disorder. J Psychiatry Neurosci. 2011;36:114.10.1503/jpn
   PubMed Web of Science ®Google Scholar
• Haji N, Mandolesi G, Gentile A, et al. TNF-α-mediated anxiety in a mouse model of multiple sclerosis. Exp Neurol. 2012;237:296–303.10.1016/j.expneurol.2012.07.010
   PubMed Web of Science ®Google Scholar
• Soczynska JK, Kennedy SH, Goldstein BI, et al. The effect of tumor necrosis factor antagonists on mood and mental health-associated quality of life: novel hypothesis-driven treatments for bipolar depression? Neurotoxicol. 2009;30:497–521.10.1016/j.neuro.2009.03.004
   PubMed Web of Science ®Google Scholar
• Haroon E, Raison CL, Miller AH. Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology. 2012;37:137–162.10.1038/npp.2011.205
   PubMed Web of Science ®Google Scholar
• Geurts JJ, Bö L, Roosendaal SD, et al. Extensive hippocampal demyelination in multiple sclerosis. J Neuropathol Exp Neurol. 2007;66:819–827.10.1097/nen.0b013e3181461f54
   PubMed Web of Science ®Google Scholar
• Papadopoulos D, Dukes S, Patel R, et al. Substantial archaeocortical atrophy and neuronal loss in multiple sclerosis. Brain Pathol. 2009;19:238–253.10.1111/bpa.2009.19.issue-2
   PubMed Web of Science ®Google Scholar
• Sicotte N, Kern K, Giesser B, et al. Regional hippocampal atrophy in multiple sclerosis. Brain. 2008;131:1134–1141.10.1093/brain/awn030
   PubMed Web of Science ®Google Scholar
• Iosif RE, Ekdahl CT, Ahlenius H, et al. Tumor necrosis factor receptor 1 is a negative regulator of progenitor proliferation in adult hippocampal neurogenesis. J Neurosci. 2006;26:9703–9712.10.1523/JNEUROSCI.2723-06.2006
   PubMed Web of Science ®Google Scholar
• Goshen I, Kreisel T, Ben-Menachem-Zidon O, et al. Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Mol Psychiatry. 2008;13:717–728.10.1038/sj.mp.4002055
   PubMed Web of Science ®Google Scholar
• Ma J, Wu CF, Wang F, et al. Neurological mechanism of Xiaochaihutang's antidepressant-like effects to socially isolated adult rats. J Pharm Pharmacol. 2016;68:1340–1349.10.1111/jphp.2016.68.issue-10
   PubMed Web of Science ®Google Scholar
• Salazar A, Gonzalez-Rivera BL, Redus L, et al. Indoleamine 2,3-dioxygenase mediates anhedonia and anxiety-like behaviors caused by peripheral lipopolysaccharide immune challenge. Horm Behav. 2012;62:202–209.10.1016/j.yhbeh.2012.03.010
   PubMed Web of Science ®Google Scholar
• Wu TC, Chen HT, Chang HY, et al. Mineralocorticoid receptor antagonist spironolactone prevents chronic corticosterone induced depression-like behavior. Psychoneuroendocrinology. 2013 Jun;38(6):871–83.
   PubMed Web of Science ®Google Scholar
• Pollak Y, Orion E, Goshen I. Experimental autoimmune encephalomyelitis-associated behavioral syndrome as a model of ‘depression due to multiple sclerosis. Brain Behav Immun 2002;16:533–543.
   PubMed Web of Science ®Google Scholar